These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20429318)

  • 41. Eletriptan treatment of migraine in patients switching from barbiturate-containing analgesics: results from a multiple-attack study.
    Martin VT; Loder E; Taylor K; Almas M; Hilliard B
    Cephalalgia; 2005 Sep; 25(9):726-34. PubMed ID: 16109055
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Large-scale screening and subsequent effects of migraine treatment on the work floor in the Netherlands.
    Mérelle SY; Couturier EG; van Bokhorst J; Busschbach JJ; Passchier J
    Cephalalgia; 2009 Jun; 29(6):606-15. PubMed ID: 19175613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Eletriptan in the early treatment of acute migraine: influence of pain intensity and time of dosing.
    Brandes JL; Kudrow D; Cady R; Tiseo PJ; Sun W; Sikes CR
    Cephalalgia; 2005 Sep; 25(9):735-42. PubMed ID: 16109056
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
    Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine.
    Krymchantowski AV; Bigal ME
    BMC Neurol; 2004 Jun; 4():10. PubMed ID: 15222892
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Eletriptan in migraine.
    Diener HC
    Expert Rev Neurother; 2005 Jan; 5(1):43-53. PubMed ID: 15853473
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
    Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW
    Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An economic evaluation of triptan products for migraine.
    Perfetto EM; Weis KA; Mullins CD; Subedi P; Healey PJ
    Value Health; 2005; 8(6):647-55. PubMed ID: 16283865
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Allodynia-associated symptoms, pain intensity and time to treatment: predicting treatment response in acute migraine intervention.
    Cady RK; Freitag FG; Mathew NT; Elkind AH; Mao L; Fisher AC; Biondi DM; Finlayson G; Greenberg SJ; Hulihan JF
    Headache; 2009 Mar; 49(3):350-63. PubMed ID: 19220503
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rizatriptan 10-mg wafer versus usual nontriptan therapy for migraine: analysis of return to function and patient preference.
    Pascual J; García-Moncó C; Roig C; Yusta Izquierdo A; López-Gil A;
    Headache; 2005 Oct; 45(9):1140-50. PubMed ID: 16178944
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Consistent efficacy, tolerability, and high levels of satisfaction with almotriptan 12.5 mg when used to treat multiple migraine attacks in routine clinical practice.
    Diener HC
    Headache; 2005 Jun; 45(6):624-31. PubMed ID: 15953293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC; Gendolla A; Gebert I; Beneke M
    Eur Neurol; 2005; 53 Suppl 1():41-8. PubMed ID: 15920337
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Eletriptan for the acute treatment of migraine: results of bridging a Japanese study to Western clinical trials.
    Sakai F; Diener HC; Ryan R; Poole P
    Curr Med Res Opin; 2004 Mar; 20(3):269-77. PubMed ID: 15025836
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Frovatriptan in the practice of office-based neurologists/pain therapists: Results of postmarketing surveillance study ALADIN.
    Wallasch TM
    Adv Ther; 2010 Jan; 27(1):56-62. PubMed ID: 20140543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comment on eletriptan in migraine patients reporting unsatisfactory response to rizatriptan.
    Rodgers A; Hustad CM; Ramsey KE; Skobieranda F
    Headache; 2007 Mar; 47(3):452; author reply 452-3. PubMed ID: 17371373
    [No Abstract]   [Full Text] [Related]  

  • 56. Migraine treatment with rizatriptan and non-triptan usual care medications: a pharmacy-based study.
    Cady R; Martin V; Adelman J; Diamond M; Sajjan S; Hu XH
    Headache; 2004 Oct; 44(9):900-7. PubMed ID: 15447699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents.
    Rothner AD; Wasiewski W; Winner P; Lewis D; Stankowski J
    Headache; 2006 Jan; 46(1):101-9. PubMed ID: 16412157
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Almotriptan for the acute treatment of adolescent migraine.
    Lewis DW
    Expert Opin Pharmacother; 2010 Oct; 11(14):2431-6. PubMed ID: 20828268
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of sinus headache as migraine: the diagnostic utility of triptans.
    Kari E; DelGaudio JM
    Laryngoscope; 2008 Dec; 118(12):2235-9. PubMed ID: 18948830
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Needle-free subcutaneous sumatriptan for triptan users requiring a change in migraine therapy: efficacy and impact on patient-rated functionality, satisfaction, and confidence.
    Rothrock JF; Cady RK; Aurora SK; Brandes JL; Myers JA; Fox AW; Farr SJ
    Curr Med Res Opin; 2011 Nov; 27(11):2185-91. PubMed ID: 21942531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.